Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings
- 27 September 2023
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 95, 129488
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP–TEAD Protein–Protein InteractionACS Medicinal Chemistry Letters, 2014
- The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatmentNature Reviews Drug Discovery, 2013
- Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAPGenes & Development, 2012
- The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewalNature Cell Biology, 2011
- Hippo signaling: growth control and beyondDevelopment, 2011
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- Structural insights into the YAP and TEAD complexGenes & Development, 2010
- Structural basis of YAP recognition by TEAD4 in the Hippo pathwayGenes & Development, 2010
- Hippo signaling in organ size controlGenes & Development, 2007
- Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determinationProceedings of the National Academy of Sciences, 2006